Capabilities
-
- Multiple antibody generation technologies
-
Company has access to multiple antibody generation technologies, including the ADLib® system that we developed of our own, and by leveraging the features of each technology in integrated manner, we select the best clone (antibody) in less time. By taking this, we raise the probability of successful antibody generation to put into pipeline.
-
- Comprehensive capabilities
-
We have platform technology that supports a wide range of drug discovery processes, not only antibody generation technology, but also technology for protein processing of such as antibody and antigen in high purity, humanization and affinity maturation, and skills and know-how for pharmacological study.
-
- Expertise and network for discovering drug seeds
-
Utilizing network of our experienced and professional researchers, we obtain licenses of promising drug seeds from academia, research institutes and biotech companies and enhance the flow of drug development conducting the early stage of drug development. Through providing such solutions, we make contribution to the wellbeing of patients and society.